Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. It offers services through the Medicare program to the federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.
Ticker
EHC
Exchange
NYSE
Sector
Healthcare
Industry
Medical Care Facilities
Market cap
$13.52B
52-week range
$92.77 - $143.36
Valuation
Share price
$137.54 (close of Nov 6, 2026)
P/E (TTM)
21.23x
Price to book
3.86x
Price to free cash flow
29.57x
Enterprise value
$16.25B
Book value per share
$35.63
Price performance
Period
Change
1 day
-2.64%
5 days
+1.21%
1 month
+10.31%
3 months
+10.19%
6 months
+30.98%
Year to date
+29.58%
1 year
+19.53%
3 years
+113.44%
5 years
+165.88%
10 years
+329.14%
All time
+3,154.36%
Short interest
As of
Oct 15, 2026
Short % of float
3.80%
Shares short
3.31M
Days to cover
3.52
Change since prior report
-5.04%
Source
FINRA consolidated short interest
Profitability and growth
Return on equity
17.60%
Return on invested capital
14.89%*
Return on assets
7.99%
Return on capital employed
17.21%*
Net margin
9.54%
EBITDA margin
20.39%
Revenue growth
10.46%
Net income growth
24.25%
Free cash flow growth
21.90%
* Estimated EBIT: pre-tax income + net interest. This company reports no operating income line.
Cash flow and balance sheet
Free cash flow yield (TTM)
3.38%
Current ratio
1.09x
Net debt to EBITDA
1.76x
Latest reported year
Period end
Dec 31, 2025
Fiscal year
2025
Revenue
$5.94B
EBITDA
$1.21B
Net income
$566.20M
Earnings per share
$5.62
Interest expense
$123.20M
Shares outstanding
100.50M
Income statement by year
Period end
Revenue
Gross profit
Net income
EPS
2025-12-31
$5.94B
-
$566.20M
$5.62
2024-12-31
$5.37B
-
$455.70M
$4.53
2023-12-31
$4.80B
-
$352.00M
$3.51
2022-12-31
$4.35B
$693.80M
$271.00M
$2.72
2021-12-31
$4.01B
$729.10M
$412.20M
$4.15
2020-12-31
$3.57B
$715.50M
$284.20M
$2.87
2019-12-31
$4.61B
$859.10M
$358.70M
$3.65
2018-12-31
$4.28B
$775.40M
$292.30M
$2.98
2017-12-31
$3.91B
$750.00M
$271.10M
$2.88
2016-12-31
$3.64B
$721.50M
$247.60M
$2.77
Margins and returns by year
Period end
Gross margin
Net margin
Return on equity
Return on capital
2025-12-31
-
9.54%
17.60%
14.89%*
2024-12-31
-
8.48%
16.32%
13.38%*
2023-12-31
-
7.33%
15.61%
11.92%*
2022-12-31
15.95%
6.23%
14.84%
9.12%
2021-12-31
18.16%
10.27%
17.49%
7.84%
2020-12-31
20.06%
7.97%
14.43%
8.87%
2019-12-31
18.66%
7.79%
21.19%
9.85%
2018-12-31
18.13%
6.83%
18.77%
10.72%
2017-12-31
19.16%
6.93%
19.43%
10.89%
2016-12-31
19.81%
6.80%
27.19%
10.80%
* Estimated EBIT: pre-tax income + net interest. This company reports no operating income line.